Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-08-16
2005-08-16
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S484000, C424S486000, C424S078080, C424S078170
Reexamination Certificate
active
06930098
ABSTRACT:
The present invention relates to the method of using polysulphated cyclodextrins or addition salts thereof for use in the treatment of arthrosis, and pharmaceutical compositions thereof.
REFERENCES:
patent: 4247535 (1981-01-01), Lewis et al.
patent: 4258180 (1981-03-01), Lewis et al.
patent: 5843920 (1998-12-01), Weisz
patent: 0447171 (1991-09-01), None
patent: 0754460 (1997-01-01), None
patent: WO 91/16905 (1991-11-01), None
patent: WO 92/13895 (1992-08-01), None
patent: WO 93/09790 (1993-05-01), None
Da Camara “Glucosamine Sulfate for Osteoarthritis,”Annals of Pharmacotherapy, vol. 32, No. 5, May 1998, pp. 580-587.
Hamerman, D. “The Biology of Osteoarthritis,”New England Journal of Medicine, vol. 320, No. 20, May 18, 1989, pp. 1322-1330.
Verbruggen August Lodewijk
Veys Eric Maximilien
Fubara Blessing
Page Thurman K.
The Firm of Hueschen and Sage
Universiteit Gent
LandOfFree
Use of polysulphated cyclodextrins for treating osteoarthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of polysulphated cyclodextrins for treating osteoarthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of polysulphated cyclodextrins for treating osteoarthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3502521